News Actavia Life Sciences, Inc.

Equities

RASP

US7538881068

Delayed OTC Markets Other stock markets 14:18:48 2024-06-21 EDT			5-day change	1st Jan Change
0.0016 ^USD	-82.22%		-82.22%	-79.22%

05-20	Actavia Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI
02-16	Actavia Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Actavia Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	05-20	CI
Actavia Life Sciences : Change in Certifying Accountants - Form 8-K	04-10	PU
Actavia Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	02-16	CI
Actavia Life Sciences, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	01-05	CI
Rasna Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	23-08-14	CI
Rasna Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2023	23-05-15	CI
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23-03-02	AQ
Rasna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2022	23-03-02	CI
RASNA THERAPEUTICS INC. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-02-09	AQ
Rasna Therapeutics, Inc. Reports Earnings Results for the Full Year Ended September 30, 2022	23-02-09	CI
Rasna Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt	23-02-08	CI
Rasna Therapeutics : Certificate of Incorporation/Bylaws - Form 8-K	23-01-23	PU
RASNA THERAPEUTICS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	23-01-23	AQ
RASNA THERAPEUTICS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	22-12-20	AQ
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-08-22	AQ
Rasna Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022	22-08-22	CI
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-06-21	AQ
Rasna Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2022	22-06-21	CI
RASNA THERAPEUTICS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-06-16	AQ
Rasna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2021	22-06-16	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Actavia Life Sciences, Inc.

Equities

RASP

US7538881068

Summary

Filters